Journal article · 2001

Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments

René S. Kahn

Evidence-based Healthcare, 5(3), 97–98 · Published 1 September 2001 · DOI 10.1016/s1462-9410(01)90422-x

View at the publisherCite this paper

In brief

“Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments” is a 2001 journal article by René S. Kahn, published in Evidence-based Healthcare. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
3
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kahn, R. S. (2001). Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments. Evidence-based Healthcare, 5(3), 97–98. https://doi.org/10.1016/s1462-9410(01)90422-x

MLA 9

Kahn, René S. “Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments.” Evidence-based Healthcare, vol. 5, no. 3, 2001, pp. 97–98. https://doi.org/10.1016/s1462-9410(01)90422-x.

Chicago

Kahn, René S. 2001. “Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments.” Evidence-based Healthcare 5 (3): 97–98. https://doi.org/10.1016/s1462-9410(01)90422-x.

Harvard

Kahn, R. S. (2001) ‘Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments’, Evidence-based Healthcare, 5(3), pp. 97–98. doi:10.1016/s1462-9410(01)90422-x.

IEEE

R. S. Kahn, “Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments,” Evidence-based Healthcare, vol. 5, no. 3, pp. 97–98, 2001, doi: 10.1016/s1462-9410(01)90422-x.

BibTeX

@article{kahn2001atypical,
  title     = {{Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments}},
  author    = {Kahn, René S.},
  journal   = {Evidence-based Healthcare},
  year      = {2001},
  volume    = {5},
  number    = {3},
  pages     = {97--98},
  doi       = {10.1016/s1462-9410(01)90422-x},
  url       = {https://doi.org/10.1016/s1462-9410(01)90422-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • typical antipsychotics
  • schizophrenia
  • treatment effectiveness
  • tolerability
  • drug efficacy comparison

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Kahn, R. S. (2001). Atypical antipsychotics are no more effective or tolerable than conventional antipsychotic schizophrenia treatments. Evidence-based Healthcare, 5(3), 97–98. https://doi.org/10.1016/s1462-9410(01)90422-x

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

René S. Kahn.

What is the DOI of this paper?

10.1016/s1462-9410(01)90422-x, permanently at https://doi.org/10.1016/s1462-9410(01)90422-x. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.